TY - JOUR AU - Vygen-Bonnet, Sabine AU - Hellenbrand, Wiebke AU - Garbe, Edeltraut AU - von Kries, Rüdiger AU - Bogdan, Christian AU - Heininger, Ulrich AU - Röbl-Mathieu, Marianne AU - Harder, Thomas PY - 2020 DA - 2020/02/13 TI - Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review JO - BMC Infectious Diseases SP - 136 VL - 20 IS - 1 AB - Infants < 3 months of age are at highest risk for developing severe complications after pertussis. The majority of pregnant women has low concentrations of pertussis-specific antibodies and thus newborns are insufficiently protected by maternally transferred antibodies. Acellular pertussis vaccination during pregnancy was recently implemented in various countries. Here, we assessed the evidence for safety and effectiveness of pertussis vaccination during pregnancy. SN - 1471-2334 UR - https://doi.org/10.1186/s12879-020-4824-3 DO - 10.1186/s12879-020-4824-3 ID - Vygen-Bonnet2020 ER -